ORMD 0901 – Oral GLP-1 for T2DM

//ORMD 0901 – Oral GLP-1 for T2DM
ORMD 0901 – Oral GLP-1 for T2DM 2018-05-30T17:03:56+00:00

Glucagon-like peptide-1 (GLP-1) is an incretin hormone that stimulates the secretion of insulin from the pancreas. Exenatide, a GLP-1 analog, is currently marketed in injectable form only, and is indicated for treatment of type 2 diabetes. Exenatide induces insulin release at increased glucose levels and causes a feeling of satiety, which results in reduced food intake and weight loss.

Oramed’s oral GLP-1 capsule based on the company’s PODTM technology could significantly increase compliance and become a valuable tool in the treatment of diabetes.